Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity
R Lang, AL Gundlach, FE Holmes, SA Hobson… - Pharmacological …, 2015 - ASPET
Galanin was first identified 30 years ago as a" classic neuropeptide," with actions primarily
as a modulator of neurotransmission in the brain and peripheral nervous system. Other …
as a modulator of neurotransmission in the brain and peripheral nervous system. Other …
Cholinergic system during the progression of Alzheimer's disease: therapeutic implications
Alzheimer's disease (AD) is characterized by a progressive phenotypic downregulation of
markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced …
markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced …
[图书][B] What's wrong with my mouse?: behavioral phenotyping of transgenic and knockout mice
JN Crawley - 2007 - books.google.com
Dr. Jacqueline N. Crawley, author of the First and Second Editions of What's Wrong with My
Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice, continues to field calls …
Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice, continues to field calls …
Hippocampal plasticity during the progression of Alzheimer's disease
Neuroplasticity involves molecular and structural changes in central nervous system (CNS)
throughout life. The concept of neural organization allows for remodeling as a compensatory …
throughout life. The concept of neural organization allows for remodeling as a compensatory …
Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer's disease
A majority of patients with Alzheimer's disease (AD) experience some form of sleep
disruption, including nocturnal sleep fragmentation, increased daytime napping, decreased …
disruption, including nocturnal sleep fragmentation, increased daytime napping, decreased …
Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors
W Froestl, A Muhs, A Pfeifer - Journal of Alzheimer's disease, 2012 - content.iospress.com
Cognitive enhancers (nootropics) are drugs to treat cognition deficits in patients suffering
from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or …
from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or …
Cholinotrophic molecular substrates of mild cognitive impairment in the elderly
Cholinergic nucleus basalis (NB) neurons provide the major cholinergic innervation to the
cortical mantle, are selectively vulnerable in late stage Alzheimer's disease (AD) and require …
cortical mantle, are selectively vulnerable in late stage Alzheimer's disease (AD) and require …
Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze
KR Bailey, MN Pavlova, AD Rohde… - Pharmacology …, 2007 - Elsevier
The neuropeptide galanin has been implicated in anxiety-related behaviors, cognition,
analgesia, and feeding in rodents. Neuromodulatory actions of galanin are mediated by …
analgesia, and feeding in rodents. Neuromodulatory actions of galanin are mediated by …
Galanin and its receptors in neurological disorders
L Lundström, A Elmquist, T Bartfai, Ü Langel - Neuromolecular medicine, 2005 - Springer
Galanin is a highly inducible neuropeptide, showing distinct up-regulation after pathological
disturbance within the nervous system. Significant increase in galanin expression is …
disturbance within the nervous system. Significant increase in galanin expression is …
Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells
G Tang, Y Wang, S Park… - Proceedings of the …, 2012 - National Acad Sciences
The neuropeptide galanin regulates numerous physiological activities in the body, including
feeding and metabolism, learning and memory, nociception and spinal reflexes, and anxiety …
feeding and metabolism, learning and memory, nociception and spinal reflexes, and anxiety …